Skip to main content
SpringerLink
Log in

Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in rats

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Antidiabetic activity of a new ultralow-dose preparation of antibodies to insulin receptor β-subunit was revealed on the model of streptozotocin diabetes in rats: treatment with this preparation in a daily dose of 2.5 ml/kg (for 50 days through a gastric tube) normalized blood glucose level, restored glucose tolerance in the oral glucose test and body weight gain, and improved animal survival. By its hypoglycemic activity and effect on glucose tolerance the preparation was not inferior to classical drugs for the treatment of types 1 and 2 diabetes mellitus insulin (12 U/kg) and glybenclamide (8 mg/kg).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. B. Antsiferov and I. I. Dedov, UKPDS Study and Fundamentals of Oral Therapy of Type 2 Diabetes: Obesity, Metabolic Syndrome, Type 2 Diabetes Mellitus [in Russian], Moscow (2000).

  2. M. I. Balabolkin, E. M. Klebanova, and V. M. Kreminskaya, Treatment of Diabetes Mellitus and Its Complications [in Russian], Moscow (2005).

  3. M. I. Balabolkin, Endocrinology [in Russian], Moscow (1998).

  4. Diabetes. World Health Organization. Information Bulletin No. 312 (2006).

  5. O. I. Epstein, M. B. Stark, A. M. Dygai, et al., Pharmacology of Ultralow Dose Antibodies to Endogenous Function Regulators [in Russian], Moscow (2005).

  6. A. Ar’Rajab and B. Ahren, Pancreas, 8, No. 1, 50–57 (1993).

    Article  PubMed  CAS  Google Scholar 

  7. R. K. Bidasee, K. Nallani, Y. Yongqi, et al., Diabetes, No. 52, 1825–1836 (2003).

  8. A. D. Bolzan and M. S. Bianchi, Mutat. Res., 512, Nos. 2–3, 121–134 (2002).

    PubMed  CAS  Google Scholar 

  9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 26,Suppl. 1, S5–S20 (2003).

  10. S. Reddy, D. Wu, and R. B. Elliott, Autoimmunity, 20, No. 2, 83–92 (1995).

    PubMed  CAS  Google Scholar 

  11. D. A. Rees and J. C. Alcolado, Diabet. Med., 22, No. 4, 359–370 (2005).

    Article  PubMed  CAS  Google Scholar 

  12. D. Zahner and W. J. Malaisse, Diabetes Res., 14, No. 3, 101–108 (1990).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Russian Ministry of Health, Volgograd State Medical University, Russia

    A. A. Spasov & M. P. Samokhina

  2. Materia Medica Holding, Moscow

    I. A. Kheyfets, J. L. Dugina, A. V. Martyushev-Poklad, S. A. Sergeeva & O. I. Epstein

Authors
  1. A. A. Spasov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. P. Samokhina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. A. Kheyfets
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. L. Dugina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. V. Martyushev-Poklad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. A. Sergeeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. I. Epstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. A. Kheyfets.

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 144, No. 7, pp. 50–53, July, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spasov, A.A., Samokhina, M.P., Kheyfets, I.A. et al. Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in rats. Bull Exp Biol Med 144, 46–48 (2007). https://doi.org/10.1007/s10517-007-0250-4

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-007-0250-4

Key Words

Search

Navigation